In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[Q]: Tribal HUD-VASH Act of 2017 (Sec. 2) This bill provides statutory authority for the Tribal HUD-VASH program, which provides rental assistance and supportive services to Indian veterans who are homeless or at risk of homelessness and living in or near an Indian area.  The United States Housing Act of 1937 is amended to direct the Department of Housing and Urban Development (HUD) to use at least 5% of rental assistance amounts under the HUD-VASH program, which provides housing assistance to homeless veterans, for the Tribal HUD-VASH program. The Tribal HUD-VASH program shall be carried out in conjunction with the Department of Veterans Affairs (VA).  HUD and the VA: (1) shall consult with tribal organizations regarding the program's design, and (2) may make program modifications after consulting with tribal organizations. Program grants shall be made to entities eligible for Native American housing assistance block grants.   HUD may make renewal grants to entities that have received prior program grants.
[A]: Tribal HUD-VASH Act of 2017


[Q]: Significant Regulation Oversight Act of 1998 - Prohibits a significant rule from taking effect before the enactment of a joint resolution described in section four of this Act comprised solely of the text of the rule. 
Requires, before a proposed significant rule takes effect as a final rule, the agency proposing the rule to submit to each House of Congress a report containing:  (1) a copy of the proposed rule; (2) a concise summary of such rule, its purpose, and anticipated effects; (3) a complete copy of any cost-benefit analysis report that has been prepared by the agency with respect to the rule; (4) an explanation of the specific statutory interpretation under which a rule is proposed; and (5) any other relevant information or requirements under any other Act and any relevant Executive order. 
Requires each House of the Congress to provide a copy of the report to the Chairman and ranking minority party member of each committee with jurisdiction over the subject matter of the report. 
States that if the Congress fails to enact a joint resolution as prescribed in this Act approving a proposed significant rule, no court or agency may infer any intent of the Congress from any action or inaction with regard to such rule or any related statute. 
(Sec. 4) Requires the majority leader of each House of the Congress to introduce (by request) a joint resolution comprised solely of the text of the proposed significant rule within three session days in the Senate or three legislative days in the House of Representatives after the date on which an agency submits the report containing the text of the proposed significant rule.  Allows any Member of either House to introduce the resolution if it is not introduced in that House as provided in the preceding sentence. 
Outlines House and Senate committee and floor procedures for approval of the joint resolution. 
(Sec. 5) Allows any existing rule to be revised or revoked in accordance with this Act if a petition for review so requests. 
(Sec. 6) Defines "significant rule" for purposes as any rule proposed by an agency that is specified or described as such in the Act that authorizes the rule. 
(Sec. 7) States that nothing in this Act applies to any rule concerning monetary policy proposed or implemented by the Board of Governors of the Federal Reserve System or the Federal Open Market Committee.
[A]: Significant Regulation Oversight Act of 1998


[Q]: Medicare Market Acquisition Drug Price Act of 2002 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to revise payment for drugs and biologicals under Medicare.Directs the Secretary of Health and Human Services, in computing the practice expense component of the Medicare physician fee schedule with respect to payment for services of oncologists, to make adjustments to an oncologist's reported medical supply expenses in order to ensure that they better reflect the actual supply costs of providing such services.
[A]:
To amend title XVIII of the Social Security Act with respect to reform of payment for drugs and biologicals under the Medicare Program.